Pilot Phase II Study: Hemodynamic Tolerance and Anti-inflammatory Effects of Esmolol During the Treatment of Septic Shock

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The purpose of this study is : - to evaluate the hemodynamic tolerance of esmolol titrated to obtain a lowering of heart rate of 10% or 20%.
Epistemonikos ID: beb7e1089bc91b8c2360b1f793a19381f2420439
First added on: May 11, 2024